CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Asston Pharmaceuticals Ltd.

NSE : BSE : 544445 ISIN CODE : INE0SJX01015Industry : Pharmaceuticals

News

  • Asston Pharma - Commencement Of Commercial Production 21 Jan 2026 | 16:33 | Dion Global

    Commencement of Commercial Production at Unit-II of Asston Pharmaceuticals Limited.more...

  • Asston Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 06 Jan 2026 | 16:50 | Dion Global

    Compliance certificate under Regulation 74(5) of SEBI (DP) Regulation 2018more...

  • Asston Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates 05 Jan 2026 | 18:20 | Dion Global

    Meeting updatemore...

  • Asston Pharma - Board Meeting Outcome for Outcome Of The Board Meeting 05 Jan 2026 | 18:18 | Dion Global

    Outcome of the Board Meeting scheduled to be held on 05th January 2026more...

  • Asston Pharma - Board Meeting Intimation for Considering Loan Facility From HDFC Bank Ltd. 02 Jan 2026 | 18:00 | Dion Global

    Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/01/2026 inter alia to conside...more...

  • Asston Pharma - Regulation 30 SEBI (LODR) Regulation Update. 14 Nov 2025 | 17:40 | Dion Global

    Intimation of the additional capacity installation at the new manufacturing unit (Unit-II) of Asston Pharmaceuticals Limited.more...

  • Asston Pharma - Unaudited Financial Results For The Half Year Ended 30Th September, 2025, Along With A Limited Review Report 14 Nov 2025 | 17:28 | Dion Global

    Unaudited Financial Results for Half Year Ended 30th September 2025 along with a limited review reportmore...

  • Asston Pharma - Board Meeting Outcome for Outcome Of Board Meeting 14 Nov 2025 | 17:19 | Dion Global

    Intimation of the Outcome of Board Meeting Scheduled to be held on 14th November 2025.more...

  • Asston Pharma - Board Meeting Intimation for Intimation Of Board Meeting 11 Nov 2025 | 15:41 | Dion Global

    Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to conside...more...

  • Asston Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025 21 Oct 2025 | 19:30 | Dion Global

    As of September 2025 50.66% is owned by Indian Promoters and 49.34% by Public. Top three Promoters holding highest number of shares of Assto...more...

  • Asston Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 17 Oct 2025 | 17:02 | Dion Global

    Submission of compliance certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) regulation 2018more...

  • Asston Pharma - General Announcement 16 Oct 2025 | 17:34 | Dion Global

    Appointment of Mr. Yogesh Supekar DIN: 11344916 as Non Executive Non Independent Director.more...

  • Asston Pharma - Meeting Updates 16 Oct 2025 | 17:30 | Dion Global

    Meeting updates of Board Meeting scheduled to be heled on 16th October 2025more...

  • Asston Pharma - Appointment of Company Secretary and Compliance Officer 16 Oct 2025 | 17:27 | Dion Global

    Appointment of Mr. Rishi Upadhaya as Company Secretary and compliance Officer of the Companymore...

  • Asston Pharma - Board Meeting Outcome for Outcome Of Board Meeting Scheduled To Be Held On 16Th October, 2025 16 Oct 2025 | 17:25 | Dion Global

    outcome of Board MeetinOmore...

  • Asston Pharma - Board Meeting Intimation for Intimitation Of Board Meeting Schedule To Be Held On 16Th October, 2025 13 Oct 2025 | 17:24 | Dion Global

    Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 inter alia t...more...

  • Asston Pharma - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) 13 Oct 2025 | 17:12 | Dion Global

    Resignation of Mr. Deven Manohar Patil from the post of Chief Financial Officermore...

  • Asston Pharma - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 13 Oct 2025 | 16:51 | Dion Global

    Resignation of Mrs. Vandana Amit Mishra from the post of Company Secretary and Compliance Officermore...

  • Asston Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates 01 Oct 2025 | 17:10 | Dion Global

    Annual General Meeting Updatemore...

  • Asston Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report 01 Oct 2025 | 17:06 | Dion Global

    Scrutinizer s report of 6th Annual General Meeting of the Companymore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex81537.7-0.94%
NSE Index25048.65-0.95%
BSE 1000 10539.53-1.37%
BSE 100LCTMC9236.63-1.13%
BSE Auto 59556.59-1.13%
BSE BasicMat7975.53-1.09%

Commodity

Gold136103-0.08%
Silver2462901.83%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 91.62(0.04 %)
GBP/INR 123.62(0.54 %)
EUR/INR 107.62(0.52 %)
JPY/INR 0.58(0.57 %)
CAD/INR 66.13(-0.46 %)
HKD/INR 11.74(-0.04 %)